Inactivation of Zika virus in plasma with amotosalen and ultraviolet A illumination

Transfusion

Volumn 56, Issue 1, 2016, Pages 33-40

  Aubry, Maite ^a   Richard, Vaea ^a   Green, Jennifer ^b   Broult, Julien ^c   Musso, Didier ^a  

^a INSTITUT LOUIS MALARDÉ   (French Polynesia)

^b Cerus Corporation   (Canada)

^c Centre Hospitalier de Polynésie Française   (French Polynesia)

Author keywords

[No Author keywords available]

Indexed keywords

AMOTOSALEN; FUROCOUMARIN DERIVATIVE; PHOTOSENSITIZING AGENT;

BLOOD SAFETY; DRUG EFFECTS; EVALUATION STUDY; HUMAN; PLASMA; PROCEDURES; RADIATION RESPONSE; ULTRAVIOLET RADIATION; VIROLOGY; VIRUS INACTIVATION; ZIKA VIRUS;

BLOOD SAFETY; FUROCOUMARINS; HUMANS; PHOTOSENSITIZING AGENTS; PLASMA; ULTRAVIOLET RAYS; VIRUS INACTIVATION; ZIKA VIRUS;

EID: 84954395363     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13271     Document Type: Article

References (48)

1. Dick GW, Kitchen SF, Haddow AJ., Zika virus. I. Isolations and serological specificity. Trans R Soc Trop Med Hyg 1952; 46: 509-20.
2. Simpson DI., Zika virus infection in man. Trans R Soc Trop Med Hyg 1964; 58: 335-8.
3. Moore DL, Causey OR, Carey DE, et al., Arthropod-borne viral infections of man in Nigeria, 1964-1970. Ann Trop Med Parasitol 1975; 69: 49-64.
4. Fagbami AH., Zika virus infections in Nigeria: virological and seroepidemiological investigations in Oyo State. J Hyg (Lond) 1979; 83: 213-9.
5. Filipe AR, Martins CM, Rocha H., Laboratory infection with Zika virus after vaccination against yellow fever. Arch Gesamte Virusforsch 1973; 43: 315-9.
6. Olson JG, Ksiazek TG, Suhandiman, et al., Zika virus, a cause of fever in Central Java, Indonesia. Trans R Soc Trop Med Hyg 1981; 75: 389-93.
7. Duffy MR, Chen TH, Hancock WT, et al., Zika virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med 2009; 360: 2536-43.
8. Cao-Lormeau VM, Roche C, Teissier A, et al., Zika virus, French Polynesia, South Pacific, 2013. Emerg Infect Dis 2014; 20: 1085-6.
9. Musso D, Nilles EJ, Cao-Lormeau VM., Rapid spread of emerging Zika virus in the Pacific area. Clin Microbiol Infect 2014; 20: O595-6.
10. Cao-Lormeau VM, Musso D., Emerging arboviruses in the Pacific. Lancet 2014; 384: 1571-2.
11. Campos GS, Bandeira AC, Sardi SI., Zika virus outbreak, Bahia, Brazil. Emerg Infect Dis 2015; 21.
12. Oehler E, Watrin L, Larre P, et al., Zika virus infection complicated by Guillain-Barre syndrome-case report, French Polynesia, December 2013. Euro Surveill 2014; 19 (9).
13. Marchette NJ, Garcia R, Rudnick A., Isolation of Zika virus from Aedes aegypti mosquitoes in Malaysia. Am J Trop Med Hyg 1969; 18: 411-5.
14. Grard G, Caron M, Mombo IM, et al., Zika virus in Gabon (Central Africa)-2007: a new threat from Aedes albopictus? PLoS Negl Trop Dis 2014; 8: e2681 -
15. Foy BD, Kobylinski KC, Chilson Foy JL, et al., Probable non-vector-borne transmission of Zika virus, Colorado, USA. Emerg Infect Dis 2011; 17: 880-2.
16. Musso D, Roche C, Robin E, et al., Potential sexual transmission of zika virus. Emerg Infect Dis 2015; 21: 359-61.
17. Besnard M, Lastere S, Teissier A, et al., Evidence of perinatal transmission of Zika virus, French Polynesia, December 2013 and February 2014. Euro Surveill 2014; 19.
18. Musso D, Nhan T, Robin E, et al., Potential for Zika virus transmission through blood transfusion demonstrated during an outbreak in French Polynesia, November 2013 to February 2014. Euro Surveill 2014; 19.
19. Allain JP, Bianco C, Blajchman MA, et al., Protecting the blood supply from emerging pathogens: the role of pathogen inactivation. Transfus Med Rev 2005; 19: 110-26.
20. Lin L, Cook DN, Wiesehahn GP, et al., Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light. Transfusion 1997; 37: 423-35.
21. TM. Transfus Med Hemother 2011; 38: 19-31.
22. Singh Y, Sawyer LS, Pinkoski LS, et al., Photochemical treatment of plasma with amotosalen and long-wavelength ultraviolet light inactivates pathogens while retaining coagulation function. Transfusion 2006; 46: 1168-77.
23. Tan LK., Evaluation of pathogen reduction systems to inactivate Dengue and Chikungunya viruses in apheresis platelets suspended in plasma. Adv Infect Dis 2013; 03: 1-9.
24. Dupuis K, Arnold D, Sawyer L., High titers of dengue virus in platelet concentrates are inactivated by treatment with amotosalen and UVA light [abstract]. Transfusion 2012; 52 (Suppl): 225A.
25. Corten L, Sawyer L, Liu W, et al., Third International Meeting on Emerging Diseases and Surveillance. Vienna, Austria. Pathogen inactivation of blood components for prevention of transfusion-transmitted emerging infectious diseases?: the INTERCEPT Blood System [Internet]. Concord (CA): Cerus Corp.; 2011 [cited 2015 Feb 18]. Available from: http://www.interceptbloodsystem.com/resource-center/scientific-publications/intercept-conference-abstracts/2011.
26. Musso D, Richard V, Broult J, et al., Inactivation of dengue virus in plasma with amotosalen and ultraviolet A illumination. Transfusion 2014; 54: 2924-30.
27. Epstein JS, Vostal JG., FDA approach to evaluation of pathogen reduction technology. Transfusion 2003; 43: 1347-50.
28. Reed L, Muench H., A simple method of estimating fifty per cent endpoints. Am J Epidemiol 1938; 27: 493-7.
29. Lanciotti RS, Kosoy OL, Laven JJ, et al., Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis 2008; 14: 1232-9.
30. Stramer SL, Hollinger FB, Katz LM, et al., Emerging infectious disease agents and their potential threat to transfusion safety. Transfusion 2009; 49 Suppl 2: 1S-29S.
31. Stramer SL., Current perspectives in transfusion-transmitted infectious diseases: emerging and re-emerging infections. ISBT Sci Ser 2014; 9: 30-6.
32. Pealer LN, Marfin AA, Petersen LR, et al., Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med 2003; 349: 1236-45.
33. Chuang VW, Wong TY, Leung YH, et al., Review of dengue fever cases in Hong Kong during 1998 to 2005. Hong Kong Med J 2008; 14: 170-7.
34. Stramer SL, Linnen JM, Carrick JM, et al., Dengue viremia in blood donors identified by RNA and detection of dengue transfusion transmission during the 2007 dengue outbreak in Puerto Rico. Transfusion 2012; 52: 1657-66.
35. Tambyah PA, Koay ES, Poon ML, et al., Dengue hemorrhagic fever transmitted by blood transfusion. N Engl J Med 2008; 359: 1526-7.
36. Gallian P, de Lamballerie X, Salez N, et al., Prospective detection of chikungunya virus in blood donors, Caribbean 2014. Blood 2014; 123: 3679-81.
37. Roth A, Mercier A, Lepers C, et al., Concurrent outbreaks of dengue, chikungunya and Zika virus infections-an unprecedented epidemic wave of mosquito-borne viruses in the Pacific 2012-2014. Euro Surveill 2014; 19 (41).
38. European Centre for Disease Prevention and Control. Zika virus infection outbreak, French Polynesia [Internet]. Stockholm: ECDC; 2014 [cited 2015 Mar 4]. Available from: http://www.ecdc.europa.eu/en/publications/Publications/Zika-virus-French-Polynesia-rapid-risk-assessment.pdf.
39. Brouard C, Bernillon P, Quatresous I, et al., Estimated risk of Chikungunya viremic blood donation during an epidemic on Reunion Island in the Indian Ocean, 2005 to 2007. Transfusion 2008; 48: 1333-41.
40. Liumbruno GM, Calteri D, Petropulacos K, et al., The Chikungunya epidemic in Italy and its repercussion on the blood system. Blood Transfus 2008; 6: 199-210.
41. Centers for Disease Control and Prevention (CDC). Detection of West Nile Virus in blood donations-United States, 2003. MMWR Morb Mortal Wkly Rep 2003; 52: 769-72.
42. Montgomery SP, Brown JA, Kuehnert M, et al., Transfusion-associated transmission of West Nile virus, United States 2003 through 2005. Transfusion 2006; 46: 2038-46.
43. Petersen LR, Busch MP., Transfusion-transmitted arboviruses. Vox Sang 2010; 98: 495-503.
44. Meny GM, Santos-Zabala L, Szallasi A, et al., West Nile virus infection transmitted by granulocyte transfusion. Blood 2011; 117: 5778-9.
45. Centers for Disease Control and Prevention (CDC). Fatal West Nile virus infection after probable transfusion-associated transmission-Colorado, 2012. MMWR Morb Mortal Wkly Rep 2013; 62: 622-4.
46. Calisher CH, Karabatsos N, Dalrymple JM, et al., Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera. J Gen Virol 1989; 70 (Pt 1): 37-43.
47. Sagripanti JL, Marschall HJ, Voss L, et al., Photochemical inactivation of alpha- and poxviruses. Photochem Photobiol 2011; 87: 1369-78.
48. Bruchmüller I, Janetzko K, Bugert P, et al., Polymerase chain reaction inhibition assay documenting the amotosalen-based photochemical pathogen inactivation process of platelet concentrates. Transfusion 2005; 45: 1464-72.